{"schema_version":"1","generated_at":"2026-11-11T23:37:44.573Z","data_as_of":"2026-11-09","url":"https://www.findmykol.com/kol/noemi-reguart","json_url":"https://www.findmykol.com/kol/noemi-reguart/profile.json","record_kind":"full","profile_kind":"research","person":{"slug":"noemi-reguart","name":"Noemí Reguart","credential":"MD","title":"Medical Oncologist. Head of the Thoracic Tumours Unit","specialty":"Medicine","therapeutic_area":"Lung","therapeutic_areas":["Lung","Oncology"],"institution":"Hospital Clínic Barcelona","institution_url":"https://www.findmykol.com/institution/hospital-cl-nic-barcelona","country":{"name":"Spain","code":"ES","status":"provisional"},"register":{"country":"ES"}},"identifiers":{"orcid":"0000-0001-8190-499X","openalex":"A5087391532"},"summary":"Noemí Reguart is Medical Oncologist. Head of the Thoracic Tumours Unit at Hospital Clínic Barcelona. OpenAlex indexes 382 publications with 20,542 citations (h-index 58); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.","overview":{"text":"Noemí Reguart is Medical Oncologist. Head of the Thoracic Tumours Unit at Hospital Clínic Barcelona. The public record shows 382 publications with 20,542 citations (h-index 58), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies. It also documents an investigator role on 5 registered clinical trials.","bullets":["Most recent indexed publication: 2026 · Clinical cancer research","Top research focus: Lung Cancer Treatments and Mutations","5 registered trials on ClinicalTrials.gov"],"generated_at":"2026-11-11"},"focus":{"indications":[{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":10},{"label":"Small Cell Lung Carcinoma","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Carcinoma, Small Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lung Diseases","therapeutic_area":"Respiratory","trials":1,"topics":0,"strength":3},{"label":"Bladder / Urothelial Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Idiopathic Pulmonary Fibrosis","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Myasthenia Gravis","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Osteoporosis","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Pulmonary Hypertension","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1}],"research_topics":["Lung Cancer Treatments and Mutations","Lung Cancer Diagnosis and Treatment","Lung Cancer Research Studies","Cancer Immunotherapy and Biomarkers","Cancer Genomics and Diagnostics"],"works_with":{"total":4,"shown":3,"withheld":1,"rows":[{"name":"Fundación GECP","trials":2,"payments":0,"mentions":2},{"name":"Fundacion Clinic per a la Recerca Biomédica","trials":1,"payments":0,"mentions":1},{"name":"GlaxoSmithKline","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":382,"cited_by_count":20542,"h_index":58,"i10_index":143,"pubmed_count":13,"latest_activity_year":2026,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07099898","title":"A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"GlaxoSmithKline","source_url":"https://clinicaltrials.gov/study/NCT07099898","trial_url":"https://www.findmykol.com/trial/NCT07099898"},{"nct":"NCT06431633","title":"Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"Fundación GECP","source_url":"https://clinicaltrials.gov/study/NCT06431633","trial_url":"https://www.findmykol.com/trial/NCT06431633"},{"nct":"NCT05384015","title":"Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Investigator","sponsor":"Fundación GECP","source_url":"https://clinicaltrials.gov/study/NCT05384015","trial_url":"https://www.findmykol.com/trial/NCT05384015"}],"source":"trials"},"payments":{"note":"Not attributed. This person has no U.S. clinical registration (NPI) on file, so industry payments cannot be reliably tied to them."},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":124,"years":{"first":2006,"last":2026},"societies":["AACR","ASCO","ASTRO","ESMO","IASLC","ISPOR Europe","SNO"],"shown":3,"withheld":121,"rows":[{"title":"Abstract 4797: Antagonistic SMAD2/3 control of TIMP-1, VEGF-A, and hypoxia signaling in myofibroblasts shapes histotype-specific angiogenesis in lung cancer","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-4797","source_url":"https://doi.org/10.1158/1538-7445.am2026-4797","status":"verified"},{"title":"Abstract 6820: Age-related clonal hematopoiesis drives immune remodeling that promotes lung cancer and alters neoadjuvant chemo-immunotherapy outcomes","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-6820","source_url":"https://doi.org/10.1158/1538-7445.am2026-6820","status":"verified"},{"title":"Abstract 761: Collagen turnover is dominated by fibrogenesis in lung adenocarcinoma and fibrolysis in lung squamous cell carcinomas.","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-761","source_url":"https://doi.org/10.1158/1538-7445.am2026-761","status":"verified"}],"source":"congress"},"publications":{"total":13,"shown":5,"withheld":8,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article","Clinical Trial, Phase II","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41961582/","status":"verified"},{"title":"Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Clinical Trial, Phase II","Journal Article","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41805895/","status":"verified"},{"title":"Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non-Small Cell Lung Cancer.","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article","Randomized Controlled Trial"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41537692/","status":"verified"},{"title":"Multimodal prehabilitation to prevent loss of cardiorespiratory fitness in patients with locally advanced lung cancer undergoing chemoimmunotherapy: protocol for a non-randomized multicentre study.","year":2025,"journal":"Translational lung cancer research","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41133003/","status":"verified"},{"title":"Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study).","year":2025,"journal":"Therapeutic advances in medical oncology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40585875/","status":"verified"}],"source":"publications"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"other","url":"https://orcid.org/0000-0001-8190-499X","status":"provisional"}]},"mentions":{"total":1,"shown":1,"rows":[{"url":"https://www.clinicbarcelona.org/en/professionals/noemi-reguart","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"Graduated in Medicine and Surgery, 1995","source_url":"https://www.clinicbarcelona.org/en/authorship/noemi-reguart","status":"verified","collected_at":"2026-11-09"},{"value":"MD, PhD","source_url":"https://www.clinicbarcelona.org/en/authorship/noemi-reguart","status":"verified","collected_at":"2026-11-09"}]},"roles":{"total":1,"shown":1,"rows":[{"value":"Chair, ESMO Nomination Committee (2025-present)","source_url":"https://oncodaily.com/career/esmo-313101","status":"provisional","collected_at":"2026-11-09"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Associate Professor, Faculty of Medicine and Health Sciences, University of Barcelona","source_url":"https://www.clinicbarcelona.org/en/authorship/noemi-reguart","status":"verified","collected_at":"2026-11-09"}]},"media":{"total":1,"shown":1,"rows":[{"value":"OncoDaily feature titled 'Noemi Reguart: Lenvatinib plus pembro in pretreated B3-thymoma and thymic carcinoma' (presented by Jordi Remon)","source_url":"https://oncodaily.com/blog/143210","status":"provisional","collected_at":"2026-11-09"}]}},"similar":[{"name":"Ignacio Wistuba","slug":"ignacio-wistuba","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ignacio-wistuba","json_url":"https://www.findmykol.com/kol/ignacio-wistuba/profile.json"},{"name":"Pasi Janne","slug":"pasi-janne","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/pasi-janne","json_url":"https://www.findmykol.com/kol/pasi-janne/profile.json"},{"name":"Julie Brahmer","slug":"julie-brahmer","institution":"Johns Hopkins University School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/julie-brahmer","json_url":"https://www.findmykol.com/kol/julie-brahmer/profile.json"},{"name":"Enriqueta Felip","slug":"enriqueta-felip","institution":"Vall d'Hebron Institute of Oncology (VHIO)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/enriqueta-felip","json_url":"https://www.findmykol.com/kol/enriqueta-felip/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"congress":121,"publications":8}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-09"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-09"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-09"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-09"}},"methodology_url":"https://www.findmykol.com/about#methodology"}